comparemela.com

Latest Breaking News On - Institutional investors weigh in on tonix pharmaceuticals - Page 1 : comparemela.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock. Separately, Dawson James initiated coverage on Tonix Pharmaceuticals in a research report on Wednesday, February 28th. They set a buy rating and a $3.00 price […]

Dawson-james
Zembrace-symtouch
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals-price-performance
Tonix-pharmaceuticals
Armistice-capital
Acadian-asset-management
News-ratings-for-tonix-pharmaceuticals-daily
Sabby-management
Free-report
Get-free-report

Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note released on Tuesday. The brokerage issued a sell rating on the stock. Separately, Dawson James started coverage on Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a buy rating and a $3.00 price target for the […]

Dawson-james
Zembrace-symtouch
Tonix-pharmaceuticals-holding-corp
Sabby-management
Geode-capital-management
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
Tonix-pharmaceuticals-stock-down
Tonix-pharmaceuticals
Jpmorgan-chase-co
Tonix-pharmaceuticals-company-profile
News-ratings-for-tonix-pharmaceuticals-daily
Armistice-capital

StockNews.com Begins Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)

StockNews.com began coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research report report published on Tuesday. The firm issued a sell rating on the stock. Tonix Pharmaceuticals Trading Up 7.5 % Shares of NASDAQ TNXP opened at $0.34 on Tuesday. The firm has a market cap of $9.21 million, a P/E […]

Zembrace-symtouch
News-ratings-for-tonix-pharmaceuticals-daily
Virtu-financial
Tonix-pharmaceuticals-holding-corp
Raymond-james-associates
Millennium-management
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
Tonix-pharmaceuticals-trading
Tonix-pharmaceuticals
Free-report
Get-free-report

Tonix Pharmaceuticals (NASDAQ:TNXP) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note published on Monday. The brokerage issued a sell rating on the stock. Tonix Pharmaceuticals Trading Down 3.4 % NASDAQ TNXP opened at $0.28 on Monday. Tonix Pharmaceuticals has a twelve month low of $0.26 and a twelve month high […]

Zembrace-symtouch
Tonix-pharmaceuticals-holding-corp
Jpmorgan-chase-co
Tonix-pharmaceuticals
News-ratings-for-tonix-pharmaceuticals-daily
Tonix-pharmaceuticals-trading-down
Northern-trust-corp
York-mellon-corp
Blackrock-inc
Charles-schwab-investment-management-inc
Institutional-investors-weigh-in-on-tonix-pharmaceuticals

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.